Projektdetaljer
Beskrivelse
An investigator initiated clinical trial of combined immunotherapy (PD1-inhibitor) and irreversible electroporation in patients with metastatic pancreatic cancer.
The aim is to examine the efficacy and safety of the combined treatment.
The aim is to examine the efficacy and safety of the combined treatment.
| Kort titel | Electroporation Potentiated Immunotherapy in Cancer – 1.st study |
|---|---|
| Akronym | EPIC-1 |
| Status | Igangværende |
| Effektiv start/slut dato | 01/01/2021 → 31/12/2025 |
Fingerprint
Udforsk forskningsemnerne, som dette projekt berører. Disse etiketter er oprettet på grundlag af de underliggende bevillinger/legater. Sammen danner de et unikt fingerprint.